Patents by Inventor Yuuji Shimojima

Yuuji Shimojima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180289730
    Abstract: An agent for applying to mucosa capable of persistently exerting a therapeutic effect on disorders such as inflammation and lesions in the mucosa even by a lower frequency of administration because the agent can stay at a diseased site for a long period of time by exhibiting a high staying property in a mucosal epithelial layer is provided, said agent for application to mucosa containing glycosaminoglycan (GAG) into which a hydrophobic group is introduced via a binding chain, as an active ingredient.
    Type: Application
    Filed: March 30, 2018
    Publication date: October 11, 2018
    Applicant: SEIKAGAKU CORPORATION
    Inventors: Kenji MIYAMOTO, Katsuya TAKAHASHI, Yuuji SHIMOJIMA
  • Publication number: 20150196574
    Abstract: An agent for applying to mucosa capable of persistently exerting a therapeutic effect on disorders such as inflammation and lesions in the mucosa even by a lower frequency of administration because the agent can stay at a diseased site for a long period of time by exhibiting a high staying properly in a mucosal epithelial layer is provided, said agent for application to mucosa containing glycosaminoglycan (GAG) into which a hydrophobic group is introduced via a binding chain, as an active ingredient.
    Type: Application
    Filed: January 20, 2015
    Publication date: July 16, 2015
    Applicant: SEIKAGAKU CORPORATION
    Inventors: Kenji Miyamoto, Katsuya Takahashi, Yuuji Shimojima
  • Patent number: 8969319
    Abstract: An agent for applying to mucosa capable of persistently exerting a therapeutic effect on disorders such as inflammation and lesions in the mucosa even by a lower frequency of administration because the agent can stay at a diseased site for a long period of time by exhibiting a high staying property in a mucosal epithelial layer is provided, said agent for application to mucosa containing glycosaminoglycan (GAG) into which a hydrophobic group is introduced via a binding chain, as an active ingredient.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: March 3, 2015
    Assignee: Seikagaku Corporation
    Inventors: Kenji Miyamoto, Katsuya Takahishi, Yuuji Shimojima
  • Publication number: 20110207695
    Abstract: An agent for applying to mucosa capable of persistently exerting a therapeutic effect on disorders such as inflammation and lesions in the mucosa even by a lower frequency of administration because the agent can stay at a diseased site for a long period of time by exhibiting a high staying property in a mucosal epithelial layer is provided, said agent for application to mucosa containing glycosaminoglycan (GAG) into which a hydrophobic group is introduced via a binding chain, as an active ingredient.
    Type: Application
    Filed: March 23, 2011
    Publication date: August 25, 2011
    Applicant: SEIKAGAKU CORPORATION
    Inventors: Kenji MIYAMOTO, Katsuya TAKAHISHI, Yuuji SHIMOJIMA
  • Publication number: 20080306022
    Abstract: An agent for applying to mucosa capable of persistently exerting a therapeutic effect on disorders such as inflammation and lesions in the mucosa even by a lower frequency of administration because the agent can stay at a diseased site for a long period of time by exhibiting a high staying property in a mucosal epithelial layer is provided, said agent for application to mucosa containing glycosaminoglycan (GAG) into which a hydrophobic group is introduced via a binding chain, as an active ingredient.
    Type: Application
    Filed: October 12, 2006
    Publication date: December 11, 2008
    Inventors: Kenji Miyamoto, Katsuya Takahashi, Yuuji Shimojima